Clinical Trial Update: Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating irinotecan plus capecitabine for advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Xeloda (capecitabine)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED